Literature DB >> 203545

Seroepidemiological studies of human papilloma virus (HPV-1) infections.

H Pfister, H zur Hausen.   

Abstract

At least two groups of human papilloma viruses can be distinguished serologically: on the one hand HPV 1-3, which are closely related but differ in the restriction enzyme pattern of their DNA, and on the other hand HPV-4. The age distributions of patients with warts induced by HPV 1-3 or by HPV-4, respectively, differ markedly. HPV 1-3 predominates between 5 and 15 years of age, whereas HPV-4 could be isolated more often between the ages of 20-25 years. The large number of HPV-1-3-induced warts in children is paralleled by a high percentage of HPV-1 antibody-positive sera in the same age group (about 50%). With increasing age the percentage of HPV-1 antibody-positive sera decline gradually. This pattern of seroreactivity was compared to that of patients with various papillomas and with several malignant tumors. There is no evidence to suggest a link between HPV 1-3 and condylomata acuminata, laryngeal papillomas or any of the malignant tumors tested.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 203545     DOI: 10.1002/ijc.2910210206

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Characterization of proteins of human papilloma viruses (HPV) and antibody response to HPV 1.

Authors:  H Pfister; H zur Hausen
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

2.  Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.

Authors:  S A Jenison; X P Yu; J M Valentine; D A Galloway
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

3.  Comparative sensitivity of the immunoelectronmicroscopy test and ELISA with intact virions in detecting HPV-1 antibodies and age distribution of these antibodies among general population and in children's homes.

Authors:  E Anisimová; P Barták; E Hamsiková; V Vonka
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 4.  Immunopathology of papillomavirus-induced tumors in different tissues.

Authors:  S Jablonska; G Orth; M A Lutzner
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Serological responses to papillomavirus group-specific antigens in women with neoplasia of the cervix uteri.

Authors:  L Dillner; J Moreno-Lopez; J Dillner
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

6.  Prevalence of antibodies to human papillomavirus type 8 in human sera.

Authors:  G Steger; M Olszewsky; E Stockfleth; H Pfister
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Two anatomoclinical types of warts with plantar localization: specific cytopathogenic effects of papillomavirus. Type I (HPV-1) and type 2 (HPV-2).

Authors:  R Laurent; J L Kienzler; O Croissant; G Orth
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

8.  Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts.

Authors:  C E Greer; C M Wheeler; M B Ladner; K Beutner; M Y Coyne; H Liang; A Langenberg; T S Yen; R Ralston
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Authors:  Woei Ling Peh; Kate Middleton; Neil Christensen; Philip Nicholls; Kiyofumi Egawa; Karl Sotlar; Janet Brandsma; Alan Percival; Jon Lewis; Wen Jun Liu; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Seroprevalence of 34 human papillomavirus types in the German general population.

Authors:  Kristina M Michael; Tim Waterboer; Peter Sehr; Annette Rother; Ulrich Reidel; Heiner Boeing; Ignacio G Bravo; Jörg Schlehofer; Barbara C Gärtner; Michael Pawlita
Journal:  PLoS Pathog       Date:  2008-06-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.